Evidence map›Paper›PMID 19429495›Full record

ReviewSeminars in cell & developmental biology2009

Signal peptide peptidases: a family of intramembrane-cleaving proteases that cleave type 2 transmembrane proteins.

Todd E Golde, Michael S Wolfe, Doron C Greenbaum

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in cell & developmental biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 62 citations in OpenAlex.

  1. Frontiers in immunology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Intramembrane Proteolysis of Astrotactins.The Journal of biological chemistry · 2017
    Article
  11. Bunyamwera orthobunyavirus glycoprotein precursor is processed by cellular signal peptidase and signal peptide peptidase.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Todd E GoldeDepartment of Neuroscience, Mayo Clinic, College of Medicine, 4500 San Pablo Road, Jacksonville, FL 32224, United States. tgolde@mayo.edu
Michael S Wolfe
Doron C Greenbaum
Brigham and Women's Hospital · USMayo Clinic in Florida · USUniversity of Pennsylvania · US

Funding

Y-SECRETASES IN ALZHEIMER'S DISEASER01NS039072 · NINDS · MAYO CLINIC JACKSONVILLE · PI GOLDE, TODD E · 2000 to 2008
$2.5M
Structure and mechanism of signal peptide peptidaseR01GM079555 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI WOLFE, MICHAEL S · 2007 to 2010
$1.3M
NIGMS NIH HHS GM79555NIGMS NIH HHS R01 GM079555NINDS NIH HHS NS39072NINDS NIH HHS R01 NS039072
6 · The paper itself

Abstract

Five genes encode the five human signal peptide peptidases (SPPs), which are intramembrane-cleaving aspartyl proteases (aspartyl I-CLiPs). SPPs have been conserved through evolution with family members found in higher eukaryotes, fungi, protozoa, arachea, and plants. SPPs are related to the presenilin family of aspartyl I-CLiPs but differ in several key aspects. Presenilins (PSENs) and SPPs both cleave the transmembrane region of membrane proteins; however, PSENs cleave type 1 membrane proteins whereas SPPs cleave type 2 membrane proteins. Though the overall homology between SPPs and PSENs is minimal, they are multipass membrane proteins that contain two conserved active site motifs YD and GxGD in adjacent membrane-spanning domains and a conserved PAL motif of unknown function near their COOH-termini. They differ in that the active site YD and GxGD containing transmembrane domains of SPPs are inverted relative to PSENs, thus, orienting the active site in a consistent topology relative to the substrate. At least two of the human SPPs (SPP and SPPL3) appear to function without additional cofactors, but PSENs function as a protease, called gamma-secretase, only when complexed with Nicastrin, APH-1 and Pen-2. The biological roles of SPP are largely unknown, and only a few endogenous substrates for SPPs have been identified. Nevertheless there is emerging evidence that SPP family members are highly druggable and may regulate both essential physiologic and pathophysiologic processes. Further study of the SPP family is needed in order to understand their biological roles and their potential as therapeutic targets.

Indexed as

Amyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesHumansModels, BiologicalPhylogenyReceptor, PAR-2Amyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesReceptor, PAR-2signal peptide peptidase

Identifiers

PMID19429495
PMCPMC6701170
OpenAlexW2030139543

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.